Top Neuroendocrine Tumor Treatment Companies, Leaders & Major Players

This list of the top companies of Neuroendocrine Tumor Treatment is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Neuroendocrine Tumor Treatment sector.

Top Neuroendocrine Tumor Treatment Companies

  1. Pfizer

  2. Novartis

  3. Ipsen

  4. Eli Lilly and Company

  5. Roche

*Disclaimer: Top companies sorted in no particular order

Neuroendocrine Tumor Treatment Market Major Players

Neuroendocrine Tumor Treatment - Competitive Concentration

Neuroendocrine Tumor Treatment Market Concentration

List of Neuroendocrine Tumor Treatment Companies

  • Novartis

  • Ipsen

  • Pfizer

  • Roche

  • Eli Lilly and Company

  • Boehringer Ingelheim

  • Bristol-Myers Squibb

  • Lantheus

  • ITM Isotope Technologies Munich

  • Crinetics Pharmaceuticals

  • Camurus AB

  • Tarveda Therapeutics

  • Hutchmed (Hutchison MediPharma)

  • Jubilant Radiopharma

  • Peptidyne Therapeutics

  • Avion Pharmaceuticals

  • Exelixis

  • Merck

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds